Pharmacokinetic and Pharmacodynamic Response after Subcutaneous Administration of a Novel Furosemide Formulation

  • Sica D
  • Muntendam P
  • DeBoer R
  • et al.
Citations of this article
Mendeley users who have this article in their library.


Background: Furosemide is the most widely used loop diuretic in the treatment of heart failure (HF). Subcutaneous (SC) use may offer a convenient lower cost alternative to IV. Conventional furosemide solution is unsuitable for SC use because of its alkaline pH (9.0). A novel buffered furosemide formulation was developed with a pH 7.4 for use with a patch pump for self-administration. This study compares SC administration of the novel formulation with IV administration of furosemide USP. Methods: This was a randomized open-label crossover study in patients with stable HF. SC administration consisted of 80 mg (8 mg/mL in 10 mL) of the novel furosemide solution with over for 5 hours using a biphasic pattern (30 mg over 60 min followed by 12.5 mg/hour for 4 hours.). IV control consisted of 80 mg furosemide administered in two divided doses 2 hours apart. Results: A total of 16 subjects completed the study. SC administration was well tolerated. Following SC administration all participants achieved therapeutic plasma levels (600 +/- 209 ng/mL) in 30 min. Furosemide exposure was similar following IV and SC infusion administration with a mean absolute bioavailability of 99.6%. Diuresis was equivalent between the two treatments from 0-8 and 0-24 hours (Table). Conclusions: SC administration of a novel buffered furosemide injection solution results in rapid (30 min) achievement of therapeutic plasma levels and complete (100%) bioavailability as compared to IV parameters. Diuresis was equivalent (102% and 103% for 0-8h and 0-24h). SC administration of a novel furosemide formulation offers a novel delivery mode for treatment of fluid overload. SC administration with a patch pump may enable a more effective at-home treatment of HF in the pre-acute or post-acute situation and reduce the dependence on increasingly cost prohibitive ER and inpatient services. (Table Presented.).




Sica, D. D., Muntendam, P., DeBoer, R. A., & Pitt, B. (2016). Pharmacokinetic and Pharmacodynamic Response after Subcutaneous Administration of a Novel Furosemide Formulation. Journal of Cardiac Failure, 22(8), S11.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free